Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Cardiovascular Clinical Research Facility (CCRF) was officially opened on Monday 20th May 2013. The facility, which is one of the core clinical research facilities of the Division of Cardiovascular Medicine, undertakes high-quality, world leading, cardiovascular clinical research.

Logo of the CCRF

Patients, public, students and staff attended the opening from 1 - 3 pm, as part of the UK Clinical Research Facility Network Open Day and International Clinical Trials Day.

CCRF provides a dedicated, staffed clinical research environment with particular expertise in echocardiography, vascular assessment (carotid and peripheral imaging, microvasculature and arterial stiffness) and clinical physiology (exercise testing, ambulatory monitoring, tilt table). The clinical areas are supported by a laboratory for sample handling and storage, offices and meeting space.

Further information can be found on the CCRF website.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’